Agreed, but FDA is watching closely. I'm seeing a trend however of regular business giving the US Fed Gov the "Whatever" and proceeding anyway. Special interests are killing the legitimacy of our government pushing technological advancements internationally. Whether its MJ or Stem Cells.
Imo, the best way to approach this is to send Clayton Parker an email and ask for the number of shares in the float. Because regardless of how many shares are noted as outstanding, the amount of shares in the float (what is available to be traded) is going to be significantly less than the outstanding....because the outstanding shares include the restricted shares, shares held by officers, and any shares that are committed for agreements...such as the YA agreement (his shares have to be set aside or "reserved" until they are gradually dispersed...just like the previous Hanover dispersement). So, taking this into consideration, the float should be significantly lower than the amount of outstanding shares.